Výsledky vyhledávání - "Michael I. Swain"

Peripheral Blood CD34 Donor Chimerism has Greater Clinical Utility Than CD3 for Detecting Relapse after Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia or Myelodysplastic Syndrome

Autor: Tongted P. Das, Daniel North, Shaun A. Fleming, Joanne L.C. Tan, Adam Ivey, Nicholas J. Cummings, Andrew Spencer, Sushrut S. Patil, Jacqueline M.L. Widjaja, Michael I. Swain, Catherine Bourke, Maureen E. O'Brien, David S. Kliman, David J. Curtis

Publikováno v: Transplantation and Cellular Therapy.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a88c89d1d796207a7a224623cedb448f
https://doi.org/10.1016/j.jtct.2023.03.025

Zobrazit plný text záznamu

Important factors in implementation of lineage-specific chimerism analysis for routine use

Autor: Maureen O'Brien, Andrew Spencer, Melinda N. Ziino, Jade L. Cooke, Sushrut Patil, David Kliman, Michael I. Swain, Jacqueline M. L. Widjaja, David J. Curtis, David A. Kipp, Tongted Das

Publikováno v: Bone Marrow Transplantation. 56:946-948

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::220b601da13a8af6805890fa63885fd3
https://doi.org/10.1038/s41409-020-01089-6

Zobrazit plný text záznamu

Important factors in implementation of lineage-specific chimerism analysis for routine use

Autor: Tongted P, Das, David A, Kipp, David S, Kliman, Sushrut S, Patil, David J, Curtis, Maureen E, O'Brien, Michael I, Swain, Jacqueline M L, Widjaja, Jade L, Cooke, Melinda N, Ziino, Andrew, Spencer

Publikováno v: Bone marrow transplantation. 56(4)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::bd7bcdfe8e7ead6b316a599c5cc127c5
https://pubmed.ncbi.nlm.nih.gov/33082555

Zobrazit plný text záznamu

The Effect of Daratumumab, Lenalidomide, Dexamethasone (DRd) on Peripheral Blood Stem Cell Mobilisation (PBSC)

Autor: Jane Estell, Michael I. Swain, Flora Yuen, Tishya Indran, Jacqueline M. L. Widjaja, Hang Quach, Anna Hutchinson, Andrew Spencer, Ian Kerridge, Craig T. Wallington-Beddoe, Wojt Janowski

Publikováno v: Blood. 138:3884-3884

Peripheral blood stem cell (PBSC) mobilisation in multiple myeloma (MM) patients after exposure to daratumumab (D), a CD38 targeting monoclonal antibody, produces a lower stem cell yield possibly due to an effect on CD34+ stem cells (Hulin et al., 20

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::ab6b8ef4077e6807a5a322ddd3603f1e
https://doi.org/10.1182/blood-2021-150444

Zobrazit plný text záznamu